FDA 483 - Coca-Cola Bottling Company of Northern New England - October 24, 2024

During an FDA contract inspection conducted by the Connecticut Department of Consumer Protection, Food & Standards Division, COCA-COLA BEVERAGES NORTHEAST, INC. at its East Hartford, CT facility underwent a regulatory review on October 24, 2025. This inspection, identified by Business ID CD000007 and Inspection CQ001197, was carried out by Inspector Jackie Espinet, with Amy Rohne acknowledging receipt of the findings on behalf of the firm.

The inspection resulted in an FDA Form 483, a document used by inspectors to notify a company's management of objectionable conditions observed during an inspection. These observations do not constitute a final agency determination of compliance but highlight areas requiring attention. A primary finding noted that "The hand sink a was not suitable in the a area." However, the inspection explicitly concluded that "NO CRITICAL VIOLATIONS FOUND AT TIME OF INSPECTION." This indicates that while a minor observation regarding facility suitability was made, no issues posing significant risks to public health or product quality were identified as critical.

In terms of regulatory framework, the inspection was an FDA contract, meaning it was conducted on behalf of the U.S. Food and Drug Administration. As a required action, the firm was informed that it could voluntarily respond to the identified deficiency in writing, either via email or physical copy, directly to the FDA. This allows the company an opportunity to address the observation and outline corrective actions, even though no critical violations were cited.